(Q36511702)

14 August 2017

1 reference

title

The glucocorticoid receptor: part of the solution or part of the problem? (English)

1 reference

14 August 2017

Carmine M Pariante

1

0 references

language of work or name

English

0 references

publication date

1 July 2006

1 reference

Journal of Psychopharmacology

14 August 2017

1 reference

14 August 2017

20

1 reference

14 August 2017

4 Suppl

1 reference

14 August 2017

79-84

1 reference

Rapid reversal of psychotic depression using mifepristone

14 August 2017

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Prednisone augmentation in treatment-resistant depression with fatigue and hypocortisolaemia: a case series.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Acquired deficit of forebrain glucocorticoid receptor produces depression-like changes in adrenal axis regulation and behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Effects of glucocorticoids on declarative memory function in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Characterization and functional significance of glucocorticoid receptors in patients with major depression: modulation by antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Regulation of adult neurogenesis by antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Ligand-independent activation of the glucocorticoid receptor by beta2-adrenergic receptor agonists in primary human lung fibroblasts and vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

The effects of cortisol infusion upon hormone secretion from the anterior pituitary and subjective mood in depressive illness and in controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

24-hour profiles of adrenocorticotropin, cortisol, and growth hormone in major depressive illness: effect of antidepressant treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

A.E. Bennett Research Award. Regulation of serotonin1A, glucocorticoid, and mineralocorticoid receptor in rat and human hippocampus: implications for the neurobiology of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Psychopathological symptoms during interferon-alpha and ribavirin treatment: effects on virologic response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Negative Immunoregulatory Effects of Antidepressants Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Circumvention of pleiotropic drug resistance in subcutaneous tumours in vivo with verapamil and clomipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Effects of cytokines on glucocorticoid receptor expression and function. Glucocorticoid resistance and relevance to depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

The phosphodiesterase type 4 inhibitor, rolipram, enhances glucocorticoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

ABCB1 (MDR1)-type P-glycoproteins at the blood-brain barrier modulate the activity of the hypothalamic-pituitary-adrenocortical system: implications for affective disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Paroxetine for the prevention of depression induced by high-dose interferon alfa

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Depression, Stress and the Adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Glucocorticoid receptor function in vitro in patients with major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Interferon alfa-induced adverse effects in patients with a psychiatric diagnosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Antidepressant fluoxetine enhances glucocorticoid receptor function in vitro by modulating membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Do antidepressants regulate how cortisol affects the brain?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

The antidepressant clomipramine regulates cortisol intracellular concentrations and glucocorticoid receptor expression in fibroblasts and rat primary neurones

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

A novel prednisolone suppression test for the hypothalamic-pituitary-adrenal axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Four days of citalopram increase suppression of cortisol secretion by prednisolone in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Antidepressants enhance glucocorticoid receptor function in vitro by modulating the membrane steroid transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Reduced glucocorticoid and estrogen receptor alpha messenger ribonucleic acid levels in the amygdala of patients with major mental illness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Depression in cancer: new developments regarding diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

The DST as a predictor of outcome in depression: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Anti-psychotic drugs reverse multidrug resistance of tumor cell lines and human AML cells ex-vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Polymorphisms in the glucocorticoid receptor gene and their associations with metabolic parameters and body composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Interleukin 1alpha (IL-1alpha) induced activation of p38 mitogen-activated protein kinase inhibits glucocorticoid receptor function

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Involvement of multidrug resistance proteins (MDR) in the modulation of glucocorticoid response

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Regional specificity of brain glucocorticoid receptor mRNA alterations in subjects with schizophrenia and mood disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Inhibition of P-glycoprotein by newer antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Cell-mediated immunity and its glucocorticoid-sensitivity after clinical recovery from severe major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Decreased expression of mineralocorticoid receptor mRNA in the prefrontal cortex in schizophrenia and bipolar disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Mineralocorticoid receptor function in major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Cortisol response in the combined dexamethasone/CRH test as predictor of relapse in patients with remitted depression. a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

Pituitary volume in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F1359786806066063

21 January 2018

Identifiers

DOI

10.1177/1359786806066063

1 reference

14 August 2017

1 reference

PubMed ID

16785275